thegalactosemiapodcast.com - support the show; ad-free and early access episodes

Links & Resources Mentioned:

Galactosemia Foundation: galactosemia.org

Dr. Berry’s Paper “Is prenatal myo-inositol deficiency a mechanism of CNS injury in galactosemia?” Link: https://drive.google.com/file/d/1nfWpURDtYK619CZbMHL0FrsHpTlyodW7/view?usp=sharing

Grant Abstract “Optimal Window of Opportunity for Granulosa Cell Gene Therapy in Galactosemia”: https://reporter.nih.gov/search/-xJ3CNT65k68090tWRqEwQ/project-details/10787066#similar-Projects

To participate in Dr. Berry’s long-term study on galactosemia outcomes, email: gerard.berry@childrens.harvard.edu

In this episode, we sit down with Dr. Gerard Berry, a world-renowned biochemical geneticist and pediatric endocrinologist, to discuss his decades of research in galactosemia. Dr. Berry shares his journey into the field, explains the complexities of the disorder, and sheds light on new potential treatments, including gene therapy and myo-inositol supplementation. He also discusses the history of galactosemia research, the challenges of treatment, and the promising future of medical advancements. This conversation is packed with fascinating insights and hope for the future.

Key Topics Discussed:

• Dr. Berry’s career and how he became a leading researcher in galactosemia

• The biochemical complexity of galactosemia and why dietary restriction alone isn’t enough

• The history of galactosemia research and how our understanding has evolved

• Potential treatments, including gene therapy, prenatal interventions, and myo-inositol supplementation

• Why galactosemia presents differently in individuals and the role of genetic modifiers

• The ethical challenges in developing new therapies

• The future of galactosemia research and what gives Dr. Berry hope

Guest Bio: Dr. Gerard Berry is a leading biochemical geneticist and pediatric endocrinologist specializing in metabolic disorders, including galactosemia. He has published over 225 peer-reviewed papers and held prestigious positions at institutions like Boston Children’s Hospital and the Broad Institute of Harvard and MIT. Dr. Berry’s groundbreaking research has advanced our understanding of galactosemia, and he continues to work toward better treatments and, ultimately, a cure.

00:00 Intro

00:02:30 - Meet Dr. Gerard Berry

00:06:30 - What is Galactosemia?

00:14:00 - The Early Days of Galactosemia Research

00:22:00 - The Biochemistry of Galactosemia

00:30:00 - Complications & Global Impact

00:38:00 - The Future of Treatment

00:46:00 - Prenatal & Early Interventions

00:53:00 - The Role of Myo-Inositol in Galactosemia

01:12:00 - Why Symptoms Vary

01:20:00 - Galactosemia Across the World

01:30:00 - Hope for the Future